ELITE PHARMACEUTIC (ELTP)

0.09
0.00 1.97
OTC
Prev Close 0.09
Open 0.09
Day Low/High 0.09 / 0.09
52 Wk Low/High 0.06 / 0.22
Volume 301.56K
Exchange OTC
Shares Outstanding 791.52B
Market Cap 70.44M
Div & Yield N.A. (N.A)

Latest News

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss Third Quarter Financial Results On February 12, 2018

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss Third Quarter Financial Results On February 12, 2018

Financials for Third Quarter Fiscal Year 2018 Ended December 31, 2017 will be released on February 9, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2018 Ended September 30, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2018 Ended September 30, 2017

Conference Call Scheduled for Friday, November 10th at 11:30 AM EST

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss Second Quarter Financial Results On September 10, 2017

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss Second Quarter Financial Results On September 10, 2017

Financials for Second Quarter Fiscal Year 2018 Ended September 30, 2017 will be released on November 9, 2017

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss First Quarter Financial Results On August 10, 2017

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss First Quarter Financial Results On August 10, 2017

Financials for First Quarter Fiscal Year 2018 Ended June 30, 2017 will be released on August 9, 2017

Elite Pharmaceuticals, Inc. Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information

Conference Call Scheduled for Thursday, June 15 at 2:00 PM EDT

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results On June 15, 2017

Financials for Fiscal Year Ended March 31, 2017 will be released on June 14, 2017

Elite Pharmaceuticals Acquires Trimipramine ANDA

Dr. Reddy's Laboratories to Provide Marketing and Sales

Elite Pharmaceuticals, Inc. Reports Results For Third Quarter Of Fiscal Year 2017

Conference Call Scheduled for Monday, February 13 at 11:30 AM EST

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss 3rd Quarter 2017 Financial Results On February 13, 2017

Financials for 3rd Quarter Ended December 31, 2016 will be released on February 9, 2017

Elite Reports On SequestOx™ FDA End-of-Review Meeting

Elite Reports On SequestOx™ FDA End-of-Review Meeting

Elite Will Proceed with Studies Required for an NDA Resubmission